Nurix Therapeutics
NRIX
NRIX
182 hedge funds and large institutions have $2.15B invested in Nurix Therapeutics in 2025 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 93 increasing their positions, 29 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
39% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 28
36.63% more ownership
Funds ownership: 110.89% → 147.52% (+37%)
5% more funds holding
Funds holding: 173 → 182 (+9)
Holders
182
Holding in Top 10
4
Calls
$4.74M
Puts
$1.63M
Top Buyers
| 1 | +$70.4M | |
| 2 | +$63.4M | |
| 3 | +$37.6M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$35.5M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$31.4M |
Top Sellers
| 1 | -$66.8M | |
| 2 | -$21.6M | |
| 3 | -$19.3M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$17.3M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$14.7M |
